Summary of novel bacterial isolates derived from human clinical specimens and nomenclature revisions published in 2018 and 2019

Erik Munson, Karen C. Carroll

Research output: Contribution to journalReview articlepeer-review

Abstract

Knowledge of novel prokaryotic taxon discovery and nomenclature revisions is of importance to clinical microbiology laboratory practice, infectious disease epidemiology, and studies of microbial pathogenesis. Relative to bacterial isolates derived from human clinical specimens, we present an in-depth summary of novel taxonomic designations and revisions to prokaryotic taxonomy that were published in 2018 and 2019. Included are several changes pertinent to former designations of or within Propionibacterium spp., Corynebacterium spp., Clostridium spp., Mycoplasma spp., Methylobacterium spp., and Enterobacteriaceae. Future efforts to ascertain clinical relevance for many of these changes may be augmented by a document development committee that has been appointed by the Clinical and Laboratory Standards Institute.

Original languageEnglish (US)
Article numbere01309-20
JournalJournal of clinical microbiology
Volume59
Issue number2
DOIs
StatePublished - Feb 2021

Keywords

  • Nomenclature
  • Prokaryotes
  • Taxonomy

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Summary of novel bacterial isolates derived from human clinical specimens and nomenclature revisions published in 2018 and 2019'. Together they form a unique fingerprint.

Cite this